Use of a new generation of capillary electrophoresis to quantify circulating free DNA in non-small cell lung cancer

Clinica Chimica Acta

Volumn 425, Issue , 2013, Pages 93-96

  Chiappetta, Caterina ^a   Anile, Marco ^a   Leopizzi, Martina ^a   Venuta, Federico ^a   Della Rocca, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Circulating free DNA; Early diagnosis; Non small cell lung cancer

Indexed keywords

BETA ACTIN; CIRCULATING FREE DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ANALYZER; ARTICLE; BETA ACTIN GENE; CANCER DIAGNOSIS; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; GENE TARGETING; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

CIRCULATING FREE DNA; EARLY DIAGNOSIS; NON-SMALL CELL LUNG CANCER;

ACTINS; ADULT; AGED; AREA UNDER CURVE; AUTOMATION, LABORATORY; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA; EARLY DIAGNOSIS; ELECTROPHORESIS, CAPILLARY; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84882762092     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.07.014     Document Type: Article

References (11)

1. Howlader N., Noone A.M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2008 2011, National Cancer Institute, Bethesda.
2. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456.
3. Lee Y.J., Yoon K.A., Han J.Y., et al. Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Clin Cancer Res 2011, 17:5179-5187.
4. Paci M., Maramotti S., Bellesia E., et al. Circulating plasma DNA as a diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009, 64:92-97.
5. Pathak A.K., Butani M., Kumar S., Mohan A., Guleria R. Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006, 52:1833-1842.
6. Travis W.D., Travis L.B., Devesa S.S. Lung cancer. Cancer 1995, 75:191-202.
7. Sozzi G., Conte D., Leon M., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003, 21:3902-3908.
8. Camps C., Sirera R., Bremnes R.M., et al. Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer. Anticancer Res 2006, 26:4905-4909.
9. Panaro N.J., Yuen P.K., Sakazume T., Fortina P., Kricka L.J., Wilding P. Evaluation of DNA fragment sizing and quantification by the Agilent 2100 Bioanalyzer. Clin Chem 2000, 46:1851-1853.
10. Hanley J.A., McNeil B.J. The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
11. Hanley J.A., McNeil B.J. A method of comparing the areas under the receiver operating characteristic (ROC) curve. Radiology 1983, 148:839-843.